An-Najah Staff

With an incidence of 130,000 per year and 50,000 cases of death in the United States alone, colorectal cancer (CRC) has matured into the second most common cancer in both sexes in the Western world.1 Up to 90% of CRC-cases originate from benign adenomas. Hence, the incidence of CRC could be considerably reduced by more than 80% if polyps were detected and eliminated before their malignant transformation. Despite the availability of several screening options, CRC remains a considerable cause of morbidity and mortality. The main reason is related to poor patient acceptance in current screening programs. Therefore, a real successful strategy has to overcome poor patient acceptance in the future by making the examinations comfortable and noninvasive. Magnetic resonance colonography (MRC) has the potential to be implemented as such a screening tool. Due to its noninvasive character, it is well accepted by patients. Moreover, it is highly accurate for the detection of colorectal polyps.

See The Attached File